Vif
Vif
批准号:
7914107
负责人:
John D Gross
金额:
$40.98万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2012-07-31
关键词:
ArchitectureBindingBoxingCellsComplementary DNAComplexCrystallographyCullin 5 ProteinCytidineCytidine DeaminaseDNA lesionDeaminaseEnzymesFamilyHIVHIV-1HIV-1 loadHIV-2MapsMutationN-terminalOligonucleotidesPrimate LentivirusesProteinsRNARecruitment ActivityResolutionReverse TranscriptionRoleSIVStructureTranscription ProcessUbiquitin-Protein Ligase ComplexesUbiquitinationViralVirusacrosome stabilizing factorapolipoprotein B mRNA editing enzymein vivomembermulticatalytic endopeptidase complexparticlepolypeptidereconstructionubiquitin-protein ligaseviral DNA
中文摘要
项目4 - Vif(彼得林和格罗斯)项目负责人)
病毒感染因子Vif是灵长类慢病毒HIV-1、HIV-2、
和SIV。如果没有Vif,这些病毒不会在非允许细胞或宿主中复制。Vif失活
细胞胞苷脱氨酶ASF和A3 G,它们是APOBEC 3(载脂蛋白B)的成员
mRNA编辑酶催化多肽3)家族。在Vif不存在的情况下,这些APOBEC 3蛋白
被整合到新的病毒颗粒中,在那里它们在负链cDNA中脱氨基胞苷,
逆转录这些DNA损伤导致病毒DNA降解或引入有害的
突变。此外,APOBEC 3蛋白可以在不存在其酶促作用的情况下抑制病毒复制。
活性,可能是通过改变逆转录过程本身。因此,APOBEC蛋白保护细胞
Vif已经进化为提供一种重要的病毒对抗防御。
Vif的一个关键作用是促进A3 G和ASF的泛素化和随后的破坏。
蛋白体Vif将A3 G和ASF募集到包括Cullin-5、Ring-box
2,以及延伸蛋白B和C(EloBC)。即使是适度抑制Vif功能,无论是通过干扰结合
A3 G和/或ASF或通过阻断EloBC/Cul 5/Rbx 2 E3连接酶的募集,可以显著降低
体内HIV-1载量。因此,本项目的一个主要目标是确定
Vif/EloBC/Cul 5/Rbx 2复合物和具有A3 G的亚复合物。
英文摘要
PROJECT 4 - Vif (PETERLIN AND GROSS. PROJECT LEADERS)
The viral infectivity factor Vif is an essential accessory protein of primate lentiviruses, HIV-1, HIV-2,
and SIV. Without Vif, these viruses do not replicate in non-permissive cells or in the host. Vif inactivates
the cellular cytidine deaminases ASF and A3G, which are members of the APOBEC3 (apolipoprotein B
mRNA-editing enzyme catalytic-polypeptides 3) family. In the absence of Vif, these APOBEC3 proteins
are incorporated into new viral particles where they deaminate cytidines in the minus-strand cDNA during
reverse transcription. These DNA lesions result in viral DNA degradation or introduction of deleterious
mutations. In addition, the APOBEC3 proteins can inhibit viral replication in the absence of their enzymatic
activity, possibly by altering the reverse transcription process itself. Thus, APOBEC proteins protect cells
against HIV, and Vif has evolved to provide an essential viral counter defense.
A key role for Vif is to promote ubiquitination and subsequent destruction of A3G and ASF by the
proteosome. Vif recruits A3G and ASF to a cellular ubiquitin protein ligase that includes Cullin-5, Ring-box
2, and Elongins B and C (EloBC). Even modest inhibition of Vif function, either by interfering with binding
to A3G and/or ASF or by blocking recruitment of the EloBC/Cul5/Rbx2 E3 ligase, might significantly reduce
HIV-1 loads in vivo. Therefore, a major objective of this project is to determine the architecture of the
Vif/EloBC/Cul5/Rbx2 complex and subcomplexes with A3G.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanisms that Control mRNA Decapping in Biological Condensates
-
批准号:10577994
-
项目类别:
-
资助金额:$31.82万
-
财政年份:2023
-
负责人:John D Gross
-
依托单位:
Project 1
-
批准号:10506987
-
项目类别:
-
资助金额:$88.22万
-
财政年份:2022
-
负责人:John D Gross
-
依托单位:
Project 1
-
批准号:10666666
-
项目类别:
-
资助金额:$90.49万
-
财政年份:2022
-
负责人:John D Gross
-
依托单位:
Conformational Control of Heterochromatin Formation by the HP-1 Protein from Fission Yeast
-
批准号:9382328
-
项目类别:
-
资助金额:$39.24万
-
财政年份:2017
-
负责人:John D Gross
-
依托单位:
Conformational Control of Heterochromatin Formation by the HP-1 Protein from Fission Yeast
-
批准号:9568786
-
项目类别:
-
资助金额:$39.24万
-
财政年份:2017
-
负责人:John D Gross
-
依托单位:
Developing Small Molecule Screens for Vif-APOBEC3 antagonists
-
批准号:9058985
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2015
-
负责人:John D Gross
-
依托单位:
DOMAIN MAPPING HIV VIF COMPLEXES BY LIMITED PROTEOLYSIS AND MASS-SPECTROMETRY
-
批准号:8363838
-
项目类别:
-
资助金额:$0.47万
-
财政年份:2011
-
负责人:John D Gross
-
依托单位:
A Combined 600 MHz NMR Console for Studies of Cell Extracts and Biological Solids
-
批准号:7791773
-
项目类别:
-
资助金额:$48.87万
-
财政年份:2010
-
负责人:John D Gross
-
依托单位:
Structure and Function of the Decapping Enzyme Complex
-
批准号:8387778
-
项目类别:
-
资助金额:$24.87万
-
财政年份:2008
-
负责人:John D Gross
-
依托单位:
Structure and Function of the Decapping Enzyme Complex
-
批准号:8889016
-
项目类别:
-
资助金额:$30.08万
-
财政年份:2008
-
负责人:John D Gross
-
依托单位:
Structure and Function of the Decapping Enzyme Complex
-
批准号:8197822
-
项目类别:
-
资助金额:$25.77万
-
财政年份:2008
-
负责人:John D Gross
-
依托单位:
Structure and Function of the Decapping Enzyme Complex
-
批准号:7740205
-
项目类别:
-
资助金额:$26.03万
-
财政年份:2008
-
负责人:John D Gross
-
依托单位:
Structure and Function of the Decapping Enzyme Complex
-
批准号:7995969
-
项目类别:
-
资助金额:$25.77万
-
财政年份:2008
-
负责人:John D Gross
-
依托单位:
Vif
-
批准号:7480039
-
项目类别:
-
资助金额:$41.27万
-
财政年份:2007
-
负责人:John D Gross
-
依托单位:
Regulation of Vif and Rewiring of Host Pathways
-
批准号:10229569
-
项目类别:
-
资助金额:$20.99万
-
财政年份:2007
-
负责人:John D Gross
-
依托单位:
Structure and Evolution of APOBEC3-Vif Interactions
-
批准号:10229568
-
项目类别:
-
资助金额:$46.6万
-
财政年份:2007
-
负责人:John D Gross
-
依托单位:
Vif
-
批准号:7671435
-
项目类别:
-
资助金额:$39.56万
-
财政年份:--
-
负责人:John D Gross
-
依托单位:
Vif
-
批准号:8318681
-
项目类别:
-
资助金额:$39.7万
-
财政年份:--
-
负责人:John D Gross
-
依托单位:
Vif
-
批准号:8119491
-
项目类别:
-
资助金额:$39.43万
-
财政年份:--
-
负责人:John D Gross
-
依托单位:
HARC Center: HIV Accessory and Regulatory Complexes
-
批准号:8927006
-
项目类别:
-
资助金额:$39.73万
-
财政年份:--
-
负责人:John D Gross
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: